Yan Jiao | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Yan Jiao | Cancer Cell Biology | Best Researcher Award

Dr. Yan Jiao, First Hospital of Jilin University, China

Dr. Yan Jiao is an accomplished Attending Physician and clinical researcher at the First Hospital of Jilin University, specializing in hepatobiliary and pancreatic diseases. With dual degrees—a Bachelor of Medicine and a Ph.D. from Jilin University—Dr. Jiao has combined clinical acumen with deep expertise in bioinformatics and statistical analysis. A prolific researcher, Dr. Jiao has published extensively on topics ranging from liver cancer and immunotherapy to the adverse effects of diagnostic dyes and post-surgical complications. Notably, Dr. Jiao has contributed to scientific integrity through independent verification of published data and has reported anomalies that led to editorial actions. Skilled in R programming and mining public health datasets, Dr. Jiao blends analytical precision with a commitment to improving patient outcomes. Recognized for a meticulous approach to research, Dr. Jiao’s work exemplifies scientific rigor and ethical responsibility, making a compelling case for the Best Researcher Award.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Outstanding Publication Record:
    Dr. Jiao has co-authored over 20 peer-reviewed journal articles in high-impact journals like Scientific Reports, International Journal of Nanomedicine, and World Journal of Gastrointestinal Surgery. The research spans critical fields like liver cancer, gastric cancer, bioinformatics, and surgical safety, demonstrating multidisciplinary excellence.

  2. High Ethical Standards:
    A rare and commendable contribution is Dr. Jiao’s work in scientific integrity—verifying published studies, detecting image manipulation, and triggering investigations into misconduct. This highlights not only academic rigor but also moral responsibility in research.

  3. Bioinformatics Expertise:
    Proficient in R programming and analysis of large public datasets (FAERS, NHANES, TCGA), Dr. Jiao merges clinical insight with data science to generate real-world impact. The capacity to handle complex data with statistical precision is vital in modern medical research.

  4. Clinical & Research Integration:
    As a practicing Attending Physician in hepatobiliary and pancreatic diseases, Dr. Jiao directly applies research outcomes to clinical settings. This dual competency strengthens translational research and improves patient-centered outcomes.

  5. Collaborative Network:
    Dr. Jiao has worked with a wide range of co-authors, showing adaptability and a collaborative spirit. This not only strengthens individual studies but also reflects influence within a broader research community.

🛠️ Areas for Improvement:

  1. Global Research Visibility:
    While Dr. Jiao has a strong publication portfolio, more engagement with global conferences, keynote presentations, and international collaborations would enhance international recognition.

  2. Grant Leadership:
    There is limited information on independent research funding or grant leadership. Applying for and leading funded projects could further establish Dr. Jiao’s credentials as a principal investigator.

  3. First-Author Publications:
    Though a frequent contributor, a higher proportion of first-author or corresponding-author roles would solidify recognition as a lead researcher, particularly in high-impact original studies.

🎓 Education:

Dr. Yan Jiao pursued both undergraduate and doctoral studies at Jilin University, one of China’s top research institutions. From 2011 to 2016, Dr. Jiao earned a Bachelor of Medicine, laying the groundwork in clinical sciences and human biology. Continuing seamlessly into advanced research, Dr. Jiao completed a Ph.D. at the same university from 2016 to 2019, with a focus on hepatobiliary diseases and translational bioinformatics. The doctoral training combined clinical exposure with robust coursework in molecular biology, epidemiology, and data science. This dual qualification reflects a rare integration of frontline medical experience and deep academic inquiry, preparing Dr. Jiao for a career at the intersection of medicine, research, and technological innovation. Throughout academic training, Dr. Jiao demonstrated a strong aptitude for evidence-based medicine and statistical modeling, gaining recognition for a disciplined and inquisitive approach. The education path reflects a trajectory of consistent excellence and interdisciplinary competence.

💼 Professional Experience:

Dr. Yan Jiao currently serves as an Attending Physician at the First Hospital of Jilin University, where the clinical focus lies in hepatobiliary and pancreatic diseases. In this role, Dr. Jiao combines patient care with research initiatives, particularly in liver cancer. Beyond clinical duties, Dr. Jiao is actively engaged in bioinformatics research, utilizing datasets like FAERS, TCGA, and NHANES to uncover patterns in disease and treatment outcomes. With expert-level proficiency in R programming, Dr. Jiao conducts complex statistical analyses and visualizations. A distinct part of Dr. Jiao’s experience involves auditing the scientific literature for data anomalies and image manipulation, contributing anonymously to investigations into research misconduct. This dual role as a clinician and data scientist uniquely positions Dr. Jiao to address both practical and theoretical challenges in healthcare. Dr. Jiao’s professional journey underscores a rare blend of technical skills, ethical vigilance, and medical expertise, reinforcing eligibility for prestigious research awards.

🔬 Research Focus:

Dr. Yan Jiao’s research is deeply rooted in hepatobiliary oncology, with a specific focus on liver cancer diagnosis, treatment strategies, and prognosis modeling. Integrating clinical insights with computational analysis, Dr. Jiao utilizes large public datasets like TCGA, FAERS, and NHANES to examine treatment efficacy, drug safety, and genetic risk factors. A significant thrust of the research lies in immunotherapy, chemoembolization techniques, and the safety of diagnostic agents like Indocyanine Green. Dr. Jiao also explores post-operative complications and gastrointestinal disorders, broadening the scope of clinical relevance. Equally important is the investigation into scientific integrity, where Dr. Jiao’s efforts in identifying manipulated data and statistical inconsistencies have led to editorial scrutiny in major journals. By bridging bioinformatics with hands-on medical practice, the research offers both theoretical advancements and actionable clinical solutions. Dr. Jiao’s focus is future-facing, centered on personalized treatment and real-world data analysis to optimize patient outcomes.

📚 Publications Top Notes:

  1. 📉 Obesity-Surgery is not the end.

  2. 💉 Landscape of transarterial chemoembolization for hepatocellular carcinoma.

  3. 🧬 Immunotherapy for metastatic gastric cancer.

  4. ⚠️ Exploring the dark side of diagnostic dyes – Indocyanine green.

  5. 🧬 Long non-coding RNA HOTAIR in liver cancer cell behavior.

  6. 🧪 Abraxane-related adverse events – FAERS decade-long analysis.

  7. 🧬 Personalized treatment of perihilar cholangiocarcinoma.

  8. 💊 Impact of immunotherapy on liver metastasis.

  9. 🏥 Incisional hernia after laparoscopic colorectal surgery.

  10. 🔍 Intestinal Behçet’s disease: Diagnosis and treatment.

🧾 Conclusion:

Dr. Yan Jiao is a highly qualified and deserving candidate for the Best Researcher Award. With an exceptional combination of clinical experience, research productivity, ethical vigilance, and bioinformatics expertise, Dr. Jiao stands out as a well-rounded and impactful medical scientist. While there is room to further elevate global visibility and leadership in grant-funded research, the current portfolio already reflects excellence in translational science and data-driven healthcare. In conclusion, Dr. Jiao’s contributions are not only prolific but principled—making this nomination both timely and justified.

baofeng wang | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. baofeng wang | Cancer Cell Biology | Best Researcher Award

Prof. baofeng wang, Department of Radiation Therapy, Second Affiliated Hospital of Medical School, Xi’an Jiaotong University, Xi’an 710004, China, China

Dr. Baofeng Wang is a Professor and Associate Chief Physician at The Second Affiliated Hospital of Xi’an Jiaotong University. He serves as Head of the Abdominal Oncology Group in the Department of Radiation Oncology and is a Master’s Supervisor. Renowned for his expertise in abdominal and liver cancers, Dr. Wang actively contributes to several professional organizations, including the Chinese Society for Radiation Oncology (CSRO). As a reviewer for top journals and a recipient of multiple prestigious research awards, his work integrates clinical excellence with cutting-edge research. He has led three national and provincial-level projects and has authored over 40 scientific articles, with more than 10 published in SCI-indexed journals. His recent work focuses on ferroptosis, immune regulation in cancer, and BNCT treatment planning, marking him as a leading figure in translational oncology research.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Academic and Clinical Leadership:

    • Professor, Associate Chief Physician, and Master’s Supervisor.

    • Head of the Abdominal Oncology Group at a leading national medical institution.

    • Actively leads and shapes treatment protocols in radiation oncology.

  2. Research Productivity and Impact:

    • Authored over 40 scientific publications, with more than 10 indexed in SCI journals.

    • Principal Investigator for 3 major funded research projects.

    • Co-investigator in 5 additional national and provincial projects.

    • Reviewer for high-impact international journals, ensuring scientific rigor in oncology research.

  3. Recognition and Awards:

    • Winner of two First Prizes for Scientific and Technological Progress in Higher Education Institutions.

    • Received a Second Prize from the Shaanxi Provincial Scientific and Technological Progress Awards.

  4. Professional Influence:

    • Holds multiple key positions in national and provincial medical societies, especially within the Chinese Society for Radiation Oncology (CSRO).

    • Active in bridging research, clinical practice, and public health education.

  5. Recent Research Focus:

    • Investigating mechanisms of radioresistance via ferroptosis and cholesterol metabolism.

    • Advancing boron neutron capture therapy (BNCT) planning and immunoregulatory pathways in breast cancer and hepatocellular carcinoma.

⚙️ Areas for Improvement:

  1. Global Collaboration:

    • While domestically influential, expanding international collaborations and partnerships could further elevate the research impact and visibility.

  2. Citation Index and Research Translation:

    • Despite a good number of publications, a higher citation count and more translational outcomes into clinical practice would strengthen the award candidacy further.

  3. Innovation Leadership:

    • Developing patents or pioneering novel therapeutic technologies would add to innovation metrics.

🎓 Education:

Dr. Baofeng Wang received rigorous academic training in the medical sciences, specializing in oncology and radiation therapy. After completing his undergraduate medical degree, he pursued postgraduate studies focused on radiation oncology and tumor biology. His advanced academic pursuits led to a comprehensive understanding of radiobiology, imaging-guided radiotherapy, and molecular oncology. He continuously updates his knowledge through professional development programs and has contributed to both educational and research domains by mentoring postgraduate students. His commitment to academic excellence is evident through his role as a Master’s Supervisor, guiding the next generation of clinical researchers. Dr. Wang’s educational background has equipped him with the skills necessary to integrate evidence-based medicine with innovative research, particularly in the fields of liver cancer and immuno-oncology.

🧪 Professional Experience:

With over 15 years of clinical and academic experience, Dr. Baofeng Wang is a leading figure in the field of radiation oncology. Currently a Professor and Associate Chief Physician, he heads the Abdominal Oncology Group at The Second Affiliated Hospital of Xi’an Jiaotong University. He has been instrumental in developing individualized radiotherapy protocols for complex tumors. His leadership roles in various national and provincial oncology organizations highlight his influence in shaping cancer treatment strategies. He has served as Principal Investigator for several research grants from the National Natural Science Foundation of China and provincial R&D bodies. Additionally, Dr. Wang plays an active role in academic peer review and science promotion in Shaanxi province. His blend of clinical acumen and research proficiency makes him a cornerstone in the advancement of radiotherapy techniques and translational oncology.

🔬 Research Focus:

Dr. Wang’s research focuses on the intersection of radiation oncology, tumor metabolism, and immunoregulation. He investigates how cellular mechanisms such as ferroptosis and cytokine modulation contribute to radioresistance and tumor progression. A major area of interest is the optimization of boron neutron capture therapy (BNCT) treatment planning, aiming to enhance therapeutic outcomes in abdominal cancers. His work also explores the role of tumor-infiltrating immune cells and how factors like interleukin-10 influence immune suppression and therapy response. By integrating molecular diagnostics with imaging-guided radiotherapy, Dr. Wang seeks to improve precision medicine strategies. His translational research aims to convert lab-based discoveries into clinically viable cancer treatments, particularly for liver, breast, and gastrointestinal cancers. Through collaborative and interdisciplinary research, Dr. Wang’s work continues to push boundaries in oncology innovation.

📚 Publications Top Notes:

  1. 🧬 Recent research progress of BNCT treatment planning system

  2. 🔗 SCARB1 links cholesterol metabolism-mediated ferroptosis inhibition to radioresistance in tumor cells

  3. 🎯 BAFF overexpression in triple-negative breast cancer promotes tumor growth by inducing IL-10-secreting regulatory B cells that suppress anti-tumor T cell responses

  4. 🛡️ Interleukin-10 overexpression in 4T1 cells: A gateway to suppressing mammary carcinoma growth

📌 Conclusion:

Dr. Baofeng Wang exemplifies the qualities of an exceptional clinical researcher, balancing leadership, clinical service, and impactful research. His contributions to radiation oncology—particularly in abdominal and liver cancers—along with national-level recognition and funding, make him a highly suitable and competitive candidate for the Best Researcher Award. Continued expansion of his international footprint and translational outputs would position him even more prominently on the global stage.

Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Prof. Dr. Sibel Elif Gultekin, Gazi University Faculty of Dentistry, Turkey

Prof. Dr. Sibel Elif Gültekin is a renowned academic and clinician in Oral Pathology and Periodontology at Gazi University Faculty of Dentistry, Türkiye. With over two decades of experience, she has significantly advanced molecular understanding of odontogenic tumors, HPV-induced oral lesions, and periodontal regeneration. Holding both DDS and Ph.D. degrees, she has led her department as Chair for 10 years and contributed globally as a visiting researcher and advisor. Her collaborations with institutions like the University of Cologne and UCSF reflect her international impact. She has published extensively in high-impact journals, authored books, and mentored numerous young researchers. Her dedication has been recognized through editorial appointments and professional society memberships. Prof. Gültekin’s translational research bridges pathology and clinical dentistry, making her a pioneer in the diagnosis and treatment of oral diseases.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Dual Specialization & Academic Leadership: Prof. Gültekin’s rare dual Ph.D. in Oral Pathology and Periodontology, along with her decade-long leadership as department chair, highlights deep academic and organizational expertise.

  2. High Research Output & Impact: With 96 publications, 50+ research projects, and citations exceeding 1300 (Google Scholar), her scholarly productivity and influence are clear. Her h-index across databases (14–17) confirms consistent academic contribution.

  3. Global Collaborations: Active collaborations with international centers like UCSF and University of Cologne underscore her role in global scientific advancement.

  4. Innovative Research Areas: She works at the forefront of molecular oncology, focusing on HPV-associated oral cancers, odontogenic tumors, and biomarkers like P16, VIM3, and PDCD4.

  5. Educational & Editorial Leadership: Served on scientific and editorial boards, symposiums, and advisory panels; she also authored 2 academic books and guided national congresses.

  6. Professional Societies: Active member of multiple esteemed societies (IAOP, ESP, EHNS, IADR), reflecting recognition in the international scientific community.

⚙️ Areas for Improvement:

  1. Clinical Translation Scaling: While her biomarker discoveries are notable, increasing efforts to lead translational clinical trials could accelerate therapeutic application.

  2. Policy Advocacy: Engaging more in international oral health policy or WHO-affiliated programs could amplify her impact beyond academia.

  3. Mentorship on Global Scale: Expanding formal international mentorship programs or fellowships could further cement her influence and legacy.

🎓 Education:

Prof. Dr. Sibel Elif Gültekin holds both DDS and Ph.D. degrees, specializing in Oral Pathology and Periodontology. She completed her undergraduate dental studies at Gazi University Faculty of Dentistry, where she later pursued her doctoral studies. Her academic training extended beyond Türkiye through international fellowships and research placements, including the prestigious Department of Medicine and Stomatology at the University of California San Francisco (UCSF) and the Institute for Pathology at the University of Cologne. Her educational journey is marked by an interdisciplinary approach, blending basic sciences and clinical applications. These robust academic foundations have positioned her as a global expert in oral cancer biomarkers, regenerative periodontology, and molecular pathology, nurturing future dentists and researchers through an integrative, evidence-based curriculum and global research exposure.

💼 Experience:

Prof. Dr. Gültekin has over 25 years of experience in dentistry, oral pathology, and periodontology. She has served as Professor and Chair of the Department of Oral Pathology at Gazi University, shaping both academic curricula and national diagnostic standards. Internationally, she collaborated with UCSF and the University of Cologne on pioneering projects in oral cancer and HPV research. Her clinical and academic background spans over 50 funded research projects, with 96 published papers in prestigious journals indexed by SCI, Scopus, and PubMed. She has contributed to oral health policy through editorial and advisory roles, including at journals like Journal of Oral Health Frontiers. Her expertise has guided scientific boards and symposia in Türkiye and beyond, particularly in head and neck pathology. She remains a sought-after consultant and reviewer, advocating for personalized medicine and molecular diagnostics in oral health.

🔬 Research Focus:

Prof. Dr. Sibel Elif Gültekin’s research centers on the molecular mechanisms of oral diseases, particularly odontogenic tumors, oral epithelial dysplasia, and HPV-induced carcinomas. She has made key contributions in identifying biomarkers such as P16, PDCD4, VIM3, and CD8+ T-cell infiltrates, enhancing early diagnosis and prognosis of oral and oropharyngeal cancers. Her research also explores microsatellite instability and loss of heterozygosity in oral squamous cell carcinoma. Additionally, she has contributed to periodontal tissue regeneration studies and the development of personalized therapeutic strategies. With over 1,300 citations and an h-index of 17 on Google Scholar, her impactful work bridges molecular science and clinical application. Collaborating with global experts in pathology, oncology, and molecular biology, Prof. Gültekin’s research not only contributes to academic literature but also informs clinical protocols and treatment pathways in modern dentistry and oral oncology.

📚 Publications Top Notes:

  • 🧬 Microsatellite Instability and Loss of Heterozygosity as Prognostic Markers in Oral Squamous Cell Carcinoma (Genes, Chromosomes and Cancer, 2024)

  • 🧪 Efficiency of B-RAF-/MEK-inhibitors in B-RAF Mutated Ameloblastoma: Case Report and Review (Heliyon, 2023)

  • 🦷 Kişiselleştirilmiş Diş Hekimliği (ADO Klinik Bilimler Dergisi, 2023)

  • 🔍 Apoptosis Related PDCD4: Promising Novel Biomarker for Early Detection of Oral Cancer (ADO Klinik Bilimler Dergisi, 2022)

  • 🛡️ PD-L1 Expression and High CD8+ Lymphocyte Infiltrate Predict Outcome in Oropharyngeal SCC (International Journal of Molecular Sciences, 2020)

🧾 Conclusion:

Prof. Dr. Sibel Elif Gültekin is a highly deserving nominee for the Best Researcher Award. Her pioneering contributions in oral pathology, particularly in molecular diagnostics and HPV-related oral oncology, place her at the forefront of dental research. Her exceptional academic record, leadership, and dedication to collaborative and translational science make her a standout candidate who embodies the spirit of innovation, mentorship, and global impact.

Dalia Saleh | Cancer Cell Biology | Innovative Research Award

Published on by Cell Biologist

Prof. Dalia Saleh | Cancer Cell Biology | Innovative Research Award

Prof. Dalia Saleh, National Research Centre, Egypt

Dr. Dalia Osama Abd El Fattah Saleh is a distinguished pharmacologist and professor at the National Research Centre, Cairo, Egypt. With a career spanning over two decades in academic and pharmaceutical research, she specializes in molecular pharmacology, experimental therapeutics, and drug development. She earned her Ph.D. and M.Sc. in Pharmacology from Cairo University, where she also completed her undergraduate pharmacy degree with honors. Dr. Saleh’s prolific contributions to science are reflected in her extensive publication record, focusing on novel therapeutic strategies against various toxicological, metabolic, and inflammatory disorders. Her collaborative efforts have led to advancements in drug signaling pathways, phytochemical pharmacology, and nanotechnology-based delivery systems. Recognized nationally for her innovation, she has received several prestigious awards. Dr. Saleh continues to shape pharmacological research through her dedication to translational science, mentorship, and participation in international seminars and training programs.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  • Extensive Academic Background: Holds a Ph.D., M.Sc., and B.Sc. in Pharmacology from Cairo University, with a clear focus on endocrine and vascular pharmacology from early in her career.

  • Distinguished Research Record: Authored over 25+ high-impact publications in peer-reviewed journals including Scientific Reports, Toxicology Reports, Biochemistry and Cell Biology, and Environmental Science and Pollution Research.

  • Novel Scientific Contributions:

    • Explores molecular pharmacology through cutting-edge therapeutic approaches like AMPK/mTOR signaling, Nrf2/NF-κB modulation, and natural compound pharmacodynamics.

    • Studies involve both synthetic and phytochemical-based interventions, representing a hybrid and innovative research style.

  • Awards and Recognition:

    • National recognition for her research quality and productivity by the National Research Centre, with awards received in 2015 and 2020.

    • Ranked 24th in the institution for publication volume in 2014—an indicator of sustained output.

  • Global Exposure: Participated in professional training programs at King’s College London, enhancing her knowledge in clinical drug development and data management—an asset for interdisciplinary and translational research.

  • Leadership and Longevity: Promoted through all academic ranks at NRC, from Research Assistant to Professor, demonstrating not only competence but leadership and mentorship over time.

Areas for Improvement:

  • Clinical Translation: While the preclinical research is extensive, initiating clinical trials or translational studies would further strengthen the real-world applicability of her findings.

  • Global Visibility: Although trained internationally, more international speaking engagements, keynote invitations, or editorial roles could enhance global recognition.

  • Interdisciplinary Projects: Expanding collaborations across fields such as bioinformatics or biotechnology could amplify the innovation aspect of her work.

🎓 Education:

Dr. Dalia Saleh obtained all her academic degrees from Cairo University’s esteemed Faculty of Pharmacy. She was awarded her Ph.D. in Pharmacology in 2012 for her thesis examining estrogen’s vascular effects in insulin-resistant, ovariectomized rats. Earlier, she earned her M.Sc. in 2009 with research on rosiglitazone’s effects in streptozotocin-induced vascular changes. Her academic journey began with a B.Sc. in Pharmacy in 2002, graduating with distinction and honors. Her strong educational foundation laid the groundwork for her innovative and interdisciplinary research spanning molecular pharmacology, toxicology, and metabolic disorders. Through continuous professional development, including modules at King’s College London, Dr. Saleh stays aligned with global standards in pharmacological science and clinical drug development. Her educational background combines academic excellence with practical research expertise, making her well-equipped to address complex biomedical challenges.

👩‍🔬 Experience:

Dr. Dalia Saleh has built a progressive research career at Egypt’s National Research Centre, beginning as a Research Assistant in 2003. Over the years, she rose through the ranks to become a Professor in 2022. She previously held positions as Researcher (2012–2017) and Assistant Professor (2017–2022). Throughout her tenure, she has actively contributed to preclinical pharmacology research, focusing on inflammation, neuroprotection, metabolic diseases, and organ toxicity. Her interdisciplinary approach integrates pharmacodynamics, molecular signaling, and therapeutic intervention studies using both synthetic and natural compounds. She has led numerous studies that explore drug mechanisms at cellular and systemic levels, often employing rodent disease models. Dr. Saleh’s active participation in international training (e.g., at King’s College London) highlights her global engagement and commitment to continuous learning. Her career reflects not only research productivity but also leadership in collaborative scientific initiatives and mentoring of emerging researchers.

🏆 Awards & Honors:

Dr. Dalia Saleh has received multiple accolades that underscore her impact in the field of pharmacology. She was honored with the 2020 Scientific Pioneers Award and the 2015 Scientific Encouragement Award from Egypt’s National Research Centre (NRC), recognizing her outstanding research contributions. In 2014, she received institutional recognition for both her high publication output (ranked 24th NRC-wide) and for publishing in a high-impact journal (impact factor 4.067). These achievements highlight her consistent scientific productivity and influence in biomedical research. Dr. Saleh’s awards reflect a career driven by innovation, rigor, and dedication to solving pressing health issues. Her work continues to be widely cited and applied in translational pharmacology, securing her reputation as a leading figure in her discipline. She remains an inspiration to peers and students alike, with a legacy of both scientific excellence and mentorship.

🔬 Research Focus:

Dr. Dalia Saleh’s research is rooted in experimental pharmacology, with an emphasis on cell signaling pathways, drug discovery, and natural compound pharmacodynamics. She investigates molecular mechanisms underlying chronic diseases such as diabetes, hepatic and renal injury, neurodegeneration, and inflammatory disorders. A recurring theme in her work is the modulation of key signaling axes (e.g., AMPK/mTOR, NF-κB, PI3K/Akt) in mitigating organ toxicity and disease progression. Her recent studies explore the pharmacological potential of phytochemicals, drug hybrids, and nanoformulations in preclinical models. Dr. Saleh also examines gender-specific pathophysiology, as seen in her Ph.D. research on estrogen’s role in vascular dysfunction. She actively integrates biochemical, histological, and behavioral endpoints to ensure translational relevance. By bridging traditional medicine and molecular pharmacology, her work contributes to next-generation therapeutics and precision medicine. Her research has both national and global impact, frequently published in high-tier journals and cited in clinical research discussions.

📚 Publications Top Notes:

  1. 🧬 Eugenol alleviates acrylamide-induced testicular toxicity via AMPK/pAKT/mTOR signaling – Scientific Reports, 2024

  2. 💊 Trimetazidine protects against cisplatin-induced neuropathy via AMPK and Nrf2 pathways – Biochemistry and Cell Biology, 2023

  3. 🧪 Chromone-thiazolopyrimidine hybrids inhibit TNF-α, IL-6, and PGE2 – Polycyclic Aromatic Compounds, 2023

  4. 🧻 Chrysin counters cyclophosphamide-induced cystitis via STAT-3 and NF-κB inhibition – Chemico-Biological Interactions, 2023

  5. 🩺 Linagliptin and L-arginine synergize in hyperacidity via EP4 upregulation – Naunyn-Schmiedeberg’s Archives of Pharmacology, 2023

  6. 🧠 L-arginine protects against hepatic encephalopathy via anti-apoptotic mechanisms – Environmental Science and Pollution Research, 2023

  7. 🌿 Calotropis procera seed oil shows anti-inflammatory and antiparasitic activity – Arabian Journal of Chemistry, 2022

  8. 🧫 Olmesartan mitigates diabetic nephropathy through TLR4/P38-MAPK modulation – European Journal of Pharmacology, 2022

  9. 🌱 Anti-fibrotic activities of Plumbago species in liver fibrosis models – Scientific Reports, 2022

  10. 🐟 Omega-3 fatty acids protect against doxorubicin-induced liver damage – Saudi Journal of Biological Sciences, 2022

Conclusion:

Dr. Dalia O. Saleh is highly suitable for the Best Researcher Award based on her prolific scientific contributions, consistent academic progression, and commitment to impactful pharmacological research. Her strength lies in combining rigorous mechanistic studies with applied therapeutic exploration, especially in inflammation, oxidative stress, and natural product pharmacology.

Muhammad Piracha | Plant Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Muhammad Piracha | Plant Cell Biology | Best Researcher Award

Dr.  Muhammad Piracha, University of Sargodha, Pakistan

Dr. Muhammad Awais Piracha is a dedicated soil scientist with a Ph.D. in Soil Science from the University of Sargodha (2020). He has specialized in the biogeochemistry of toxic metals and the remediation of contaminated soils using organic amendments such as biochar, compost, and farmyard manure. His academic journey has been marked by significant contributions to plant physiology under metal stress conditions like arsenic and cadmium. Dr. Piracha gained international exposure as a Visiting Research Scholar at Texas A&M University under the HEC-funded IRSIP program. He is currently serving as Assistant Professor at the College of Agriculture, University of Sargodha. With 18 research articles, a book chapter, and multiple presentations at international conferences, he is recognized for his scientific rigor and impactful research. His work has earned him prestigious accolades, including the Agricultural Youth Leadership Award, reflecting his potential as one of Pakistan’s leading young researchers in environmental and agricultural sciences.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Solid Academic Foundation: Ph.D. in Soil Science with a strong focus on environmental toxicology and remediation.

  2. Innovative Research: Specialized in phytoremediation of toxic heavy metals (arsenic, cadmium) using sustainable organic amendments.

  3. International Recognition: Selected as a Visiting Scholar at Texas A&M University under the IRSIP (HEC Pakistan), reflecting global acknowledgment of research potential.

  4. Publication Record: Published 18 peer-reviewed research articles, 1 book chapter, and 4 abstracts, with growing citations—showing significant contributions to scientific literature.

  5. Awards & Distinctions: Winner of the Agricultural Youth Leadership Award (NAYC, 2019), demonstrating leadership in the agricultural research community.

  6. Teaching & Mentorship: Currently serving as Assistant Professor, actively engaged in knowledge transfer and capacity building in soil science.

  7. Conference Participation: Presented at multiple international conferences, staying engaged in scholarly discourse.

⚠️ Areas for Improvement:

  1. Wider International Collaboration: Although he has had international exposure, forming long-term collaborative projects or co-authoring with international teams could increase impact.

  2. Grant Acquisition: Securing research grants or funded projects from national or international agencies would strengthen his research leadership profile.

  3. Public Engagement & Policy Impact: Translating research into policy briefs, extension programs, or community impact projects could enhance visibility and societal relevance.

  4. Diversification of Research Themes: Expansion into emerging topics such as climate-smart agriculture, nanotechnology in soil science, or AI in precision agriculture could broaden research scope.

🎓 Education:

Dr. Muhammad Awais Piracha holds a Ph.D. in Soil Science from the University of Sargodha (2013–2020), where his research centered on toxic metal biogeochemistry, phytoremediation, and plant stress physiology. He previously earned an M.Sc. (Hons.) in Soil Science from the University of Agriculture, Faisalabad (2011–2013), conducting advanced studies in soil salinity, water management, and soil fertility. His undergraduate studies were also at the University of Agriculture, Faisalabad, culminating in a B.Sc. (Hons.) in Agriculture with a major in Soil Science (2007–2011). Throughout his academic journey, he demonstrated exceptional analytical and experimental skills, contributing to scientific understanding in both national and international settings. A notable highlight of his Ph.D. studies was his selection for the International Research Support Initiative Program (IRSIP), allowing him to conduct research at Texas A&M University, USA. His academic training blends theoretical depth with practical expertise in modern soil and environmental science.

💼 Experience:

Dr. Piracha has over a decade of hands-on and academic experience in soil and environmental sciences. Since September 2023, he has been serving as an Assistant Professor in the Department of Soil & Environmental Sciences, College of Agriculture, University of Sargodha. Prior to that, he worked as a Scientific/Agriculture Officer (Lab) at the Soil and Water Laboratory for Research in D.G. Khan from April 2022 to June 2023. He also held the position of Lab Chemist at Alpha Seed Corporation, Mian Channu, District Khanewal, from November 2021 to March 2022. His career reflects a strong commitment to research, academic instruction, and practical application of soil remediation technologies. In addition to his teaching responsibilities, he has conducted lab-based research, published scientific articles, and mentored students, making him a well-rounded academician and researcher in the domain of sustainable agriculture and environmental management.

🏅 Awards and Honors:

Dr. Muhammad Awais Piracha’s academic excellence and scientific contributions have earned him prestigious accolades. He was awarded the International Research Support Initiative Program (IRSIP) fellowship by the Higher Education Commission (HEC) of Pakistan during his Ph.D. studies, allowing him to conduct collaborative research at Texas A&M University, USA. In recognition of his leadership and research in agriculture, he received the Agricultural Youth Leadership Award in 2019 from the National Agricultural Youth Commission (NAYC) Pakistan. These honors reflect both national and international acknowledgment of his work in soil science, particularly in the areas of soil contamination, phytoremediation, and plant stress physiology. In addition to these formal awards, his consistent presence in international conferences and active participation in scholarly forums underscores his commitment to knowledge exchange and scientific innovation. His award history positions him as a strong contender for the Best Researcher Award, with demonstrated impact and leadership in his field.

🔬 Research Focus:

Dr. Piracha’s research focuses on soil biogeochemistry, particularly the dynamics of arsenic and cadmium in different soil textures. He explores phytoremediation techniques using organic amendments such as biochar, compost, and farmyard manure to reduce toxic metal mobility and improve soil health. His work also delves into the physiological responses of plants under heavy metal stress, aiming to understand tolerance mechanisms and improve crop resilience. Another area of focus includes the interaction between soil salinity, sodicity, and boron toxicity, crucial for arid and semi-arid agricultural systems. His integrated approach combines soil chemistry, plant physiology, and environmental sustainability, making his research highly relevant to modern agricultural challenges. By bridging lab-based experiments with field applicability, Dr. Piracha contributes to both academic knowledge and practical agricultural improvement. His efforts in sustainable soil management underscore his eligibility for recognition as a leading researcher in environmental and soil sciences.

📚 Publications Top Notes:

  1. 🧪 Arsenic behavior in different textured soils amended with phosphate rock and farm yard manure – J. Environ. Agric. (2016)

  2. 🔬 The production of biochar and its possible effects on soil properties and phosphate solubilizing bacteria – J. Appl. Agric. Biotechnol. (2016)

  3. 🌱 Growth behavior of tomato under drought stress with silicon and PGPR – Soil Environ. (2016)

  4. 💧 Challenges and opportunities for using wastewater in agriculture: A review – J. Appl. Agric. Biotechnol. (2017)

  5. 🔥 Optimization of nitrogen regulates ionic homeostasis and quality of maize under salinity – Environ. Exp. Bot. (2024)

  6. 🌻 Arsenic fractionation and physiological response in sunflower in calcareous soils – Environ. Sci. Pollut. Res. (2019)

  7. ⚗️ Alteration in arsenic dynamics in response to phosphorus in textured soils – Chemosphere (2022)

  8. 🌾 Adequate nutrient regulation improves cotton adaptability under salinity stress – J. Appl. Agric. Biotechnol. (2016)

  9. 🌿 Bio-associative effect of rhizobacteria on mungbean under saline conditions – J. Appl. Agric. Biotechnol. (2016)

  10. 🚜 Farm yard manure and nutrients improve cotton adaptation to salinity – Internal paper (details inferred)

📝 Conclusion:

Dr. Muhammad Awais Piracha is a highly suitable candidate for the Best Researcher Award. His deep specialization in soil biogeochemistry and phytoremediation, strong academic publication record, international exposure, and commitment to teaching and mentoring make him an outstanding contributor to environmental and agricultural sciences. With minor enhancements in international collaboration and grant leadership, he is well on track to becoming a leading figure in sustainable soil and environmental management.

Amal Zaher | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Amal Zaher | Microbial Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Amal Zaher , Beni-suef University , Egypt

Dr. Amal Zaher Shehata Mohamad is an Egyptian chemical and environmental engineering researcher with over two decades of academic and industrial experience. Born on March 6, 1978, she currently serves as an Associate Professor at the Department of Environmental Science and Industrial Development, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, Egypt. Dr. Zaher’s work bridges environmental sustainability and nanotechnology, focusing on wastewater treatment and advanced material applications. With a strong background in safety and occupational health, her research integrates real-world industry needs with academic innovation. She has published extensively in high-impact journals and has contributed to book chapters and international conferences. Her collaborative nature and interdisciplinary expertise have made her a respected voice in environmental science across Egypt and beyond.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Extensive Research Output: Dr. Zaher has authored over 20 peer-reviewed articles, conference papers, and book chapters, covering highly relevant environmental topics like wastewater treatment, nanotechnology, and advanced materials.

  2. Interdisciplinary Expertise: She bridges chemical engineering and environmental science, with a strong focus on Layered Double Hydroxides (LDHs), MOFs, nanofibers, and photocatalysis, demonstrating deep technical versatility.

  3. Real-World Relevance: Her research is oriented toward practical environmental applications—such as the degradation of pollutants and water purification—contributing to sustainable development and public health.

  4. Longstanding Academic and Industrial Experience: Dr. Zaher combines over 20 years of experience in engineering practice, health & safety, and academic teaching, giving her research both depth and applicability.

  5. Global Contributions: Participation in international conferences and publication in high-impact journals (e.g., Fuel, Scientific Reports, Environmental Science and Pollution Research) demonstrates global recognition.

  6. Leadership and Mentorship: As an Associate Professor, she plays a key role in mentoring postgraduate students, leading interdisciplinary projects, and promoting research at Beni-Suef University.

🔄 Areas for Improvement:

  1. International Collaborations: While she has collaborated widely within Egypt, expanding joint projects with international institutions or labs would elevate her global research profile.

  2. Patent or Commercial Applications: Filing patents or translating her nanomaterials research into industrial or commercial solutions would further enhance her impact.

  3. Research Funding and Grants: More visibility in securing or leading national/international research grants would strengthen her academic leadership credentials.

  4. Citation Impact: While she publishes frequently, focused efforts on publishing in journals with higher citation indices or review papers may increase her scientific impact.

🎓 Education:

Dr. Amal Zaher holds a B.Sc. with Honors in Chemical Engineering from Minia University, Egypt (2000). She later earned her M.Sc. in Chemical Engineering from the same institution in 2006 with a thesis focused on innovative techniques for treating oil-polluted wastewater. Driven by her interest in sustainable environmental technologies, she continued her academic pursuits and received her Ph.D. in Environmental Science and Industrial Development, further enhancing her knowledge in advanced oxidation processes and nanomaterials for wastewater treatment. Her educational background merges rigorous engineering principles with environmental applications, making her a versatile researcher in tackling industrial pollution challenges. Her academic training provided the foundation for a distinguished career in teaching, safety management, and cutting-edge scientific research.

💼 Experience:

Dr. Amal Zaher began her professional journey as a freelance engineer (2000–2002) before working as a specialist in safety and occupational health at the Manpower and Immigration Department in Minia, Egypt (2002–2016). She transitioned into academia in 2013 as an Assistant Professor at the Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University (BSU), later promoted to Associate Professor. With her diverse background, she has contributed significantly to environmental safety and pollution control both in practice and in theory. Her hands-on experience in industrial environments enhances her teaching and research, enabling her to address real-world problems with academic solutions. Dr. Zaher has led and collaborated on numerous projects related to wastewater treatment, nanomaterials, and environmental remediation, establishing herself as an expert and mentor in the field.

🔬 Research Focus:

Dr. Amal Zaher’s research centers around advanced materials and processes for environmental remediation, particularly in water and wastewater treatment. Her work explores the use of layered double hydroxides (LDH), metal-organic frameworks (MOFs), and nanostructures in removing pollutants like heavy metals, pharmaceuticals, and dyes. She is known for her contributions to photocatalytic degradation using processes such as Photo-Fenton and her innovative use of zeolite templates and metal doping to enhance adsorptive efficiency. Her recent projects delve into electrocatalytic and antibacterial applications of nanomaterials, as well as solar desalination. Her multidisciplinary approach—combining chemical engineering, environmental science, and materials chemistry—supports sustainable water management. Through publications, book chapters, and international presentations, Dr. Zaher has advanced global knowledge on pollution control and eco-friendly technologies.

📚 Publications Top Notes:

  1. ⚗️ Using Advanced Oxidation Process for Oily Water Clean-up

  2. 🌿 Optimization of a Simulated Photo-Fenton Process for Treating Olive Mill Wastewater

  3. 🔬 Influences of Tungsten Incorporation on Ni/C Nanostructures for Urea Elimination

  4. 💊 Zn/Fe LDH for Removal of Oxytetracycline: Experimental & Molecular Simulations

  5. 🌞 Photocatalytic Degradation of Phenol Wastewater: Photo Fenton Optimization

  6. 🧪 Nickel Doped Carbon Nanofibers with Tungsten for Ethanol Oxidation

  7. 💧 La-doped Zn-Fe LDH for Tetracycline Adsorption from Water

  8. 🧱 LDH Nanocubes with Zeolite Templates for Adsorbent Applications

  9. 🎨 Physicochemical Properties of Zn–Fe LDH for Dye Removal

  10. 🧼 Photocatalytic Degradation of Dye Wastewater with ZnO Nanoparticles

📌 Conclusion:

Dr. Amal Zaher Shehata Mohamad is a highly suitable candidate for the Best Researcher Award. Her work stands out for its relevance, innovation, and impact in solving critical environmental challenges through scientific research. With her impressive record of publications, dedication to teaching and mentoring, and alignment with sustainable development goals, she exemplifies the caliber of a leading researcher. Addressing a few strategic improvements could make her a globally recognized name in environmental science and nanotechnology.

Noureddine Allouche | Molecular Mechanisms Signaling | Best Research Article Award

Published on by Cell Biologist

Prof. Noureddine Allouche | Molecular Mechanisms Signaling | Best Research Article Award

Prof. Noureddine Allouche , Faculty of Sciences of Sfax, University of Sfax , Tunisia

Professor Noureddine Allouche, born in 1971, is a Full Professor of Chemistry at the Faculty of Sciences of Sfax (FSS), Tunisia. He is the Head of the Natural Substances Team in the Laboratory of Organic Chemistry. With over 150 peer-reviewed publications, an h-index of 35, and more than 4500 citations, he is recognized for his impactful research on natural products and environmental valorization. He has led and contributed to multiple national and European research projects, including FP7, H2020, Erasmus+, and ARIMNET. His work focuses on extraction, isolation, and bioactivity of plant-based compounds and sustainable management of industrial waste. Prof. Allouche has supervised 20 Ph.D. theses and 42 M.Sc. students, contributing significantly to scientific advancement in Tunisia and beyond. He is also involved in applied research in green chemistry and cosmetic sciences. His collaborative work and leadership have earned him recognition in the academic and research communities.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. High Research Productivity and Impact

    • Over 150 peer-reviewed scientific articles with a h-index of 35 and 4,500+ citations, which reflect sustained academic influence and quality.

    • Contributor to top-tier journals such as Plants, Biomolecules, and Molecules.

  2. Strong Focus on Societal Relevance

    • Work addresses critical environmental issues such as olive mill waste valorisation, bioconversion, and sustainable resource use.

    • Research applied in green chemistry, natural product-based pharmaceuticals, and eco-cosmetics.

  3. International Collaboration and Leadership

    • Coordinator of six major European and international research projects (FP7, H2020, Erasmus+, ARIMNET).

    • Active partnerships with institutions in France, Germany, and the Mediterranean region, showcasing leadership in multidisciplinary and multinational research.

  4. Methodological Rigor and Innovation

    • Use of advanced analytical techniques (e.g., HPLC-HESI-MS/MS, LC-MS/MS, ESI-MS/MS).

    • Integration of green technologies for natural substance extraction.

  5. Mentorship and Academic Development

    • Supervised 20 Ph.D. theses (plus 4 ongoing), 42 Master’s theses, and numerous diploma projects, especially in applied fields like cosmetic science.

🛠️ Areas for Improvement:

  1. Broader International Recognition

    • While highly active in regional and EU collaborations, increased visibility in global North America/Asia-led consortia or global forums could enhance recognition.

  2. Science Communication and Outreach

    • Publishing in public engagement platforms or delivering talks/webinars to non-specialist audiences could expand the impact of his research beyond academia.

  3. Open Access and Data Sharing

    • Encouraging open data practices and reproducibility of extraction and formulation protocols could enhance scientific transparency and citations.

🎓 Education:

Professor Noureddine Allouche earned his Ph.D. in Chemistry from the University of Sfax between 2000 and 2005, focusing on the treatment and valorisation of olive mill waste, a subject that would lay the foundation for his future research career. Following this, he undertook a prestigious postdoctoral training (2006–2007) at the Institute of Natural Products Chemistry of CNRS in Gif-sur-Yvette, France, enhancing his expertise in natural substances and analytical chemistry. His academic foundation was built on rigorous training in organic chemistry, natural products, and environmental biotechnology. These experiences equipped him with robust research methodologies and an interdisciplinary approach, especially in the extraction and biological evaluation of phytochemicals. His educational path reflects a strong commitment to green and sustainable chemistry, positioning him well for leading high-impact research on natural product development and eco-friendly industrial applications.

💼 Experience:

Professor Allouche has over 20 years of academic and research experience. He currently leads the Natural Substances Team at the Faculty of Sciences of Sfax and supervises a group of over 20 researchers. He has played a vital role in international research collaborations, serving as the national coordinator of six European-funded projects under FP7, ARIMNET, H2020, Erasmus+, and PHC-Maghreb. His experience also includes participation in the INCO-MED project on detoxification and recovery from olive mill wastewater. Prof. Allouche has an extensive mentoring portfolio, having supervised 20 Ph.D. theses (with 4 ongoing) and 42 M.Sc. students. He has authored 150+ articles, two book chapters, and holds two patents. His career reflects a blend of scientific innovation and applied industrial research, particularly in green technologies, bioactive compounds, and waste valorisation. He is also a regular collaborator with European institutions, reflecting his global outlook and leadership in sustainable science.

🔍 Research Focus:

Prof. Noureddine Allouche’s research centers on natural substances chemistry, green extraction methods, and biotechnological valorisation of industrial wastes, particularly from agro-food sources. He has made significant contributions to the identification and biological evaluation of bioactive compounds such as phenolics, flavonoids, and essential oils. His team is particularly active in analyzing plant extracts for their antioxidant, antimicrobial, cytotoxic, and anti-aging activities, often employing advanced techniques like HPLC, LC-MS/MS, and ESI-MS/MS. Another pillar of his work includes developing biopesticides and bio-cosmetics through green and eco-sustainable approaches. He contributes to nanoformulation research and the design of nature-based products aligned with circular economy principles. His interdisciplinary projects bridge chemistry, pharmacology, environmental science, and cosmetic formulation, making his research highly relevant for addressing current scientific and industrial challenges. His recent involvement in projects like GreenCosmIn and 25MAG23 reflects his leading role in European research on sustainable innovation.

📚 Publications Top Notes:

  1. 🌿 HPLC-HESI-MS/MS Analysis of Phenolic Compounds from Cynoglossum tubiflorus Leaf Extracts (Plants, 2024)

  2. 🫒 Intensification of Biophenols Extraction Yield from Olive Pomace Using Innovative Green Technologies (Biomolecules, 2022)

  3. 🌸 Antioxidant and Antimicrobial Activities of Erodium arborescens Extracts Characterized by LC-HESI-MS² (Molecules, 2022)

  4. 🌿 ESI-MS/MS Analysis of Aeonium arboreum Leaf Extracts and Evaluation of Antioxidant and Antimicrobial Activities (Molecules, 2021)

  5. 🍇 Novel Natural Products for Healthy Ageing from Mediterranean Diet – The MediHealth Project (Molecules, 2018)

🧾 Conclusion:

Professor Noureddine Allouche stands out as a highly qualified and deserving candidate for the Best Research Article Award. His impressive record in sustainable chemistry, natural products research, international project coordination, and scholarly mentorship underlines his academic excellence and real-world impact. His research directly contributes to health, environmental sustainability, and circular economy principles, aligning well with the goals of high-impact, solution-driven science.

Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Prof. Dr. Sibel Elif Gultekin , Gazi University Faculty of Dentistry , Turkey

Prof. Dr. Sibel Elif Gültekin is an accomplished academic and researcher in Oral Pathology and Periodontology at Gazi University, Ankara. With dual DDS and Ph.D. degrees, she has led the Department of Oral Pathology for a decade and significantly contributed to understanding oral cancer, odontogenic lesions, and HPV-related pathologies. Her collaborative research with institutions such as UCSF and the University of Cologne has yielded numerous high-impact publications and advancements in oral diagnostics. She has authored two books and published over 96 articles in reputable journals. A prominent figure in national and international research boards, Dr. Gültekin has also played a pioneering role in establishing oral pathology as a specialty in Türkiye. Her work integrates molecular biology with clinical oral health, emphasizing innovation, collaboration, and translational science. Recognized globally, she continues to mentor emerging scholars while contributing to policy-making and curriculum development in dental education.

Publication Profile:

Orcid

✅ Strengths for the Award:

  • Extensive Research Portfolio: Over 96 peer-reviewed publications, with 40 in SCI journals, reflects consistent scholarly productivity and scientific depth.

  • Citation Impact: High citation indices (Google Scholar: 1,381, h-index: 17) demonstrate strong academic influence and relevance in the field of molecular oral pathology.

  • International Collaborations: Long-term, productive collaborations with prestigious institutions including the University of Cologne and UCSF underline global recognition and trust.

  • Focused Expertise: Specialization in oral epithelial dysplasia, HPV-associated oral/oropharyngeal cancers, and molecular mechanisms of odontogenic lesions aligns closely with cutting-edge cell biology and translational research.

  • Academic Leadership: Established the Department of Oral Pathology in Türkiye and mentored future scientists, contributing to both academic infrastructure and talent development.

  • Editorial and Advisory Roles: Active roles in scientific boards and journals underscore her influence in shaping academic discourse and peer-review standards.

🛠 Areas for Improvement:

  • Patent Development: Incorporating translational research into patentable diagnostics or therapeutics would enhance practical impact and innovation scoring.

  • Funding & Industry Engagement: Broader engagement with industry-funded projects and clinical trials could further expand her work’s translational potential and outreach.

  • Global Clinical Guidelines Influence: Participation in international committees that develop clinical practice guidelines would strengthen policy-level impact.

🎓 Education:

Prof. Dr. Sibel Elif Gültekin pursued her initial dental training and later earned dual Ph.D. degrees in Periodontology and Oral Pathology, demonstrating a unique interdisciplinary depth. She completed her undergraduate and doctoral education at Gazi University, Faculty of Dentistry, Ankara. Her academic journey also included prestigious international research fellowships at the University of Cologne (Germany) and the University of California, San Francisco (UCSF, USA), where she focused on advanced molecular mechanisms in oral diseases, especially HPV-related oncogenesis and tissue regeneration. Her training reflects a blend of clinical excellence and a strong foundation in molecular biology and translational research. Through a blend of local and global academic exposure, Dr. Gültekin has acquired cutting-edge knowledge and technical expertise, which she continues to leverage in her teaching and research. Her international education and academic credentials have contributed to building strong scientific bridges between Türkiye and the global dental research community.

🧪 Professional Experience:

Prof. Dr. Sibel Elif Gültekin has over 20 years of academic and research experience in dentistry, with a specialized focus on Oral Pathology and Periodontology. She currently serves as a full professor and head of the Oral Pathology Department at Gazi University Faculty of Dentistry, a position she has held for more than a decade. Dr. Gültekin has actively engaged in research collaborations with renowned institutions such as the University of Cologne and UCSF, significantly contributing to the fields of oral cancer and molecular diagnostics. She has completed over 50 research projects and advised numerous postgraduate theses. As a scientific advisor and board member for several national and international journals and associations, she plays a pivotal role in shaping academic and clinical standards. Her editorial appointments and leadership in symposia highlight her commitment to academic excellence and global research integration. She continues to lead innovation in oral health education and research policy.

🔬 Research Focus:

Dr. Gültekin’s research centers on the molecular pathology of oral diseases, with particular emphasis on oral epithelial dysplasia, HPV-induced oral/oropharyngeal cancers, and the genetic underpinnings of odontogenic tumors and cysts. Her studies have investigated biomarkers such as p16, PDCD4, and VIM3, enabling improved early detection and classification of oral malignancies. She is also involved in exploring microsatellite instability, loss of heterozygosity, and B-RAF/MEK inhibition in the context of oral and maxillofacial tumors. A major dimension of her work includes periodontal tissue regeneration and molecular mechanisms of tooth development, which bridges clinical periodontology with developmental biology. Her research is translational, aiming to bridge bench-to-chairside pathways, and supports the development of personalized diagnostic and therapeutic strategies. With over 1,300 citations and active involvement in global research initiatives, her investigations have significantly influenced current understanding and clinical approaches in oral pathology.

📄 Publications Top Notes:

  1. 🧬 Microsatellite Instability and Loss of Heterozygosity as Prognostic Markers in Oral Squamous Cell Carcinoma – Genes, Chromosomes and Cancer (2024)

  2. 💊 Efficiency of B-RAF-/MEK-inhibitors in B-RAF mutated Ameloblastoma: Case report and review – Heliyon (2023)

  3. 🦷 Kişiselleştirilmiş Diş Hekimliği (Personalized Dentistry) – ADO Klinik Bilimler Dergisi (2023)

  4. 🧪 Apoptosis Related PDCD4: Promising Novel Biomarker for Early Detection of Oral Cancer – ADO Klinik Bilimler Dergisi (2022)

  5. 🧫 PD-L1 Expression and CD8+ Lymphocyte Infiltration Predict Outcome in Oropharyngeal Squamous Cell Carcinoma – IJMS (2020)

🔍 Conclusion:

Prof. Dr. Sibel Elif Gültekin stands out as an exceptional and qualified candidate for the Best Researcher Award. Her work in the field of oral pathology and molecular diagnostics not only contributes to advancing science but also bridges basic research with clinical applications. With a solid foundation in interdisciplinary science, international collaboration, and academic leadership, she exemplifies the values the award seeks to honor. Her achievements strongly align with the criteria of sustained research excellence, innovation, and global impact.

minghe luo | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Mr. minghe luo | Microbial Cell Biology | Best Researcher Award

Mr. minghe luo , Chongqing University of Technology , China

Dr. Minghe Luo, born in April 1984, is an accomplished pharmaceutical scientist and Associate Professor at Chongqing University of Technology. Specializing in natural product biosynthesis, he has made significant contributions to the discovery of novel antibiotics and the mechanistic understanding of biosynthetic pathways from marine microorganisms. His academic journey has taken him through respected institutions including Wuhan University and Southwest University, with extensive research training at the South China Sea Institute of Oceanology. Known for his collaborative spirit and deep expertise in medicinal chemistry, Dr. Luo has authored numerous impactful publications in journals like Angewandte Chemie and Organic Letters. His work not only advances scientific knowledge but also offers practical implications for antibiotic development. A dedicated educator and researcher, Dr. Luo continues to explore microbial biosynthetic machinery, aiming to discover new therapeutics for drug-resistant infections.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Depth of Expertise:
    Dr. Luo has solid academic foundations with a PhD in Pharmacy and a Master’s in Medicinal Chemistry of Natural Products. His specialty in natural products biosynthesis—particularly from marine microorganisms—positions him uniquely in pharmaceutical research.

  2. Research Output & Impact:
    He has authored over 15 research papers in high-impact journals such as Angewandte Chemie, Organic Letters, Chemical Engineering Journal, and Journal of Natural Products. His work tackles urgent global needs, like antibiotic resistance, with research on compounds targeting MRSA and other drug-resistant pathogens.

  3. Innovation in Biosynthesis:
    His research on trans-AT polyketide synthases, novel biosynthetic pathways, and genome mining for cryptic natural products exemplifies forward-thinking, interdisciplinary science.

  4. Independent Research and Teaching:
    As an Associate Professor, he leads independent projects while teaching and mentoring students—demonstrating both leadership and academic service.

  5. Collaboration:
    His co-authored papers reflect strong collaborative ties, including with international researchers like Prof. Jeroen Dickschat (Germany), a mark of scientific credibility and connectivity.

⚠️ Areas for Improvement:

  1. Patent/Translational Outputs:
    While his publications are excellent, showcasing patents, industry collaborations, or drug development pipelines would better demonstrate translational relevance.

  2. Global Outreach:
    Participation in international conferences, scientific boards, or as an editorial reviewer could enhance his global visibility.

  3. Public Engagement:
    Greater involvement in public science communication or outreach could boost his societal impact profile.

🎓 Education:

Dr. Minghe Luo earned his Doctorate in Pharmacy from Wuhan University (2018–2021), under the supervision of Prof. Yuhui Sun, focusing on the biosynthesis of natural products. Prior to this, he completed a Master’s degree in Medicinal Chemistry of Natural Products through a joint program between Southwest University and the South China Sea Institute of Oceanology (2008–2011), guided by Professors Zichuan Bai and Jianhua Ju. His postgraduate training emphasized the chemical characterization and bioactivity of marine-derived fungal metabolites. This unique blend of pharmacy and chemistry, alongside rigorous experimental research, laid the foundation for his expertise in microbial natural product discovery and biosynthesis. Dr. Luo’s academic development reflects a deep commitment to both theoretical understanding and applied research, equipping him with the tools to lead investigations into novel bioactive compounds, particularly those from extreme marine environments.

💼 Experience:

Dr. Luo began his career as a research scientist at the Third Affiliated Hospital of the Third Military Medical University (2011–2018), focusing on microbial natural product discovery. In 2021, he joined Chongqing University of Technology as an Associate Professor, where he leads independent projects on biosynthetic pathway elucidation and engineering of marine microbial metabolites. His role includes teaching pharmacy courses and mentoring graduate students. Dr. Luo’s experience spans isolation, structural elucidation, and genetic manipulation of microbial strains to unlock cryptic biosynthetic potential. His consistent publication record demonstrates both foundational research and innovative biosynthetic strategies. Over the years, he has cultivated a reputation for high-quality research and collaborative spirit, contributing significantly to antibiotic and anticancer compound discovery pipelines. He is particularly recognized for exploring deep-sea actinomycetes, making meaningful strides in developing novel antibacterial agents against drug-resistant pathogens.

🔬 Research Focus:

Dr. Luo’s research centers on the biosynthesis of microbial natural products, particularly from marine-derived actinomycetes and fungi. His primary interests include identifying novel polyketides, non-ribosomal peptides, and hybrid metabolites with antibacterial or anticancer potential. He employs genome mining, biosynthetic gene cluster (BGC) characterization, and pathway engineering to discover and optimize the production of bioactive compounds. A key theme in his work is understanding the mechanisms of tailoring enzymes (e.g., methyltransferases, P450s, dehydrating modules) that diversify natural product structures. Dr. Luo has also made major strides in elucidating biosynthetic pathways like those for hangtaimycin and streptovaricins. He is passionate about translating his findings into new drug leads, particularly targeting MRSA and multi-drug-resistant infections. His interdisciplinary approach bridges organic chemistry, synthetic biology, and pharmacology, contributing to the broader field of drug discovery from marine natural sources.

📚 Publications Top Notes:

  1. 🧪 The mechanism of dehydrating bimodules in trans-AT polyketide biosynthesis: hangtaimycin study – Angew. Chem. Int. Edit.

  2. 🧬 Methylation in hangtaimycin biosynthesis and its antibacterial activities – Synth. Syst. Biotechnol.

  3. 💊 Local delivery of deep marine equisetin via PVP nanofibers for anti-MRSA – Chem. Eng. J.

  4. 🌊 Natural siderophore acremonpeptides and their aluminum complex from Acremonium – J. Nat. Prod.

  5. 🔬 Amino acid-conjugated anthraquinones from marine Penicillium sp. – J. Nat. Prod.

  6. 🌐 Halogenated anthraquinones from Aspergillus sp. – J. Nat. Prod.

  7. 🧫 Genome-based mining of carpatamides I–M and their biosynthetic gene cluster – Mar. Drugs

  8. 🌿 Antibacterial lobophorin L and M from marine Streptomyces sp. – Nat. Prod. Res.

  9. 🧪 Two new streptovaricin derivatives from Streptomyces spectabilis mutants – Nat. Prod. Res.

  10. ⚗️ Mycophenolic acid derivative from Penicillium sp. fermentation – Nat. Prod. Res.

🧾 Conclusion:

Dr. Minghe Luo clearly exhibits the scientific rigor, innovation, and productivity deserving of the Best Researcher Award. His contributions to the field of natural product chemistry and biosynthesis, especially in the context of antimicrobial resistance, are both timely and impactful. With minor improvements in translational output and international visibility, he is poised to become a leading figure globally in pharmaceutical biotechnology.

Lingyan Zhou | Cell Death Pathway | Best Researcher Award

Published on by Cell Biologist

Dr. Lingyan Zhou | Cell Death Pathway | Best Researcher Award

Dr. Lingyan Zhou , Shandong Provincial Hospital Affiliated to Shandong First Medical University , China

Dr. Lingyan Zhou is a dedicated neuroscientist and clinician specializing in the pathogenesis of neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease. Currently serving in the Department of Neurology at Shandong Provincial Hospital affiliated with Shandong First Medical University, Dr. Zhou holds a doctorate and has made notable contributions to neurodegeneration research through high-impact publications and cutting-edge studies. Her work focuses on molecular mechanisms such as protein aggregation, homocysteinylation, and neuroprotection, with particular attention to α-synuclein and DJ-1. Dr. Zhou has co-authored more than 15 peer-reviewed articles in top-tier journals like Nature Communications, Science Advances, and Aging Cell, earning recognition for her insights into disease-modifying pathways. A researcher with a strong translational focus, she bridges the gap between bench and bedside, aiming to develop therapeutic strategies that can mitigate or reverse neurodegenerative processes. Her commitment to science and patient-centered research makes her a strong candidate for the Best Researcher Award.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Strong Publication Record in High-Impact Journals
    Dr. Zhou has consistently published in top-tier journals such as Nature Communications, Science Advances, Aging Cell, and Movement Disorders, reflecting the significance and innovation of her work. Many of these are Q1 journals with high impact factors.

  2. Focused Research on Neurodegeneration
    Her core focus on the molecular basis of Alzheimer’s and Parkinson’s disease, especially novel mechanisms like N-homocysteinylation, STAT1-PARP1, and microRNA signaling, demonstrates depth and relevance to global health priorities.

  3. Translational Impact
    Her research bridges basic science and clinical application, particularly through studies on neuroprotection, early disease biomarkers, and potential therapeutic targets.

  4. Early Career Excellence
    Despite being in the early stages of her career, Dr. Zhou has already authored or co-authored over 17 peer-reviewed publications, many as first or corresponding author, which is exceptional at this stage.

  5. Multidisciplinary Collaborations
    Dr. Zhou’s collaborations with experts across genetics, immunology, bioinformatics, and neurology highlight her integrative approach to complex diseases.

  6. International Visibility
    Multiple articles are indexed in PubMed, Crossref, and DOIs, showing her research has international academic presence and reach.

⚠️ Areas for Improvement:

  1. Greater International Exposure
    While her publication record is strong, further participation in international neuroscience conferences, workshops, or global consortia would enhance visibility and foster leadership roles.

  2. Grant Leadership and Independent Funding
    As she progresses, securing independent research funding and leading grant-funded projects will further demonstrate research independence and strengthen her candidacy for top-tier awards.

  3. Mentorship and Teaching Roles
    Involvement in structured mentorship or supervision of Ph.D./postdoctoral researchers could be better highlighted to show contributions to research training and capacity building.

  4. Innovation Translation Pathway
    Filing patents or initiating translational collaborations with biotech/pharma could underline the practical applicability of her findings.

🎓 Education:

Dr. Lingyan Zhou received her doctorate from Wuhan University, one of China’s leading research institutions, between September 2020 and June 2023. During her Ph.D. training, she developed expertise in molecular neuroscience and translational medicine, with a specific focus on the pathological mechanisms underlying Parkinson’s and Alzheimer’s diseases. Her research explored cellular stress pathways, protein misfolding, and epigenetic regulation in neurodegeneration, leading to multiple first-author publications in high-impact journals. Her academic background provided a solid foundation in experimental techniques such as immunohistochemistry, gene expression analysis, and in vivo disease modeling. The interdisciplinary approach at Wuhan University enriched her understanding of both clinical neurology and basic neuroscience. This rigorous academic training has equipped Dr. Zhou with the analytical and research skills necessary for advancing innovation in neurodegenerative disease treatment.

🧪 Experience:

Since July 2023, Dr. Lingyan Zhou has been serving in the Department of Neurology at Shandong Provincial Hospital affiliated with Shandong First Medical University, where she engages in both clinical practice and translational neuroscience research. Prior to that, she completed her doctoral studies at Wuhan University, where she developed a deep interest in the role of homocysteine metabolism and genetic regulation in Parkinson’s disease. Over her career, she has collaborated with multidisciplinary teams to investigate molecular and cellular mechanisms of neurodegeneration and published extensively in internationally recognized journals. Her current position allows her to continue high-impact research while mentoring junior colleagues and participating in multi-center studies. Her combined experience in basic research, clinical neurology, and academic collaboration has established her as a key contributor in the field of neurodegenerative diseases, positioning her well for leadership roles and research recognition such as the Best Researcher Award.

🧠 Research Focus:

Dr. Lingyan Zhou’s research is centered on understanding the molecular and cellular mechanisms that drive neurodegenerative diseases, with an emphasis on Alzheimer’s and Parkinson’s disease. Her work has shed light on pathological protein modifications, such as N-homocysteinylation of α-synuclein and DJ-1, which contribute to protein aggregation and neurotoxicity. Additionally, she investigates the neuroprotective roles of vitamins, retinoic acid, and microRNAs in slowing disease progression. Dr. Zhou is also exploring how infectious diseases like SARS-CoV-2 may trigger or exacerbate neurological disorders, expanding the understanding of systemic factors in brain health. Her studies leverage both in vitro and in vivo models to unravel pathways involving STAT1, PARP1, and Notch signaling. By identifying potential therapeutic targets and biomarkers, her research aims to guide the development of novel treatment strategies that could improve outcomes for patients suffering from movement disorders and cognitive decline.

📚 Publications Top Notes:

  1. 🧪 N-homocysteinylation of alpha-synuclein promotes its aggregation and neurotoxicity – Aging Cell (2022)

  2. 🧠 Association of vitamin B2 intake with cognitive performance in older adults: a cross-sectional study – J Transl Med (2023)

  3. 🧬 Homocysteine and Parkinson’s disease – CNS Neurosci Ther (2023)

  4. 🧴 Retinoic Acid Prevents alpha-Synuclein Preformed Fibrils-Induced Toxicity via Inhibiting STAT1-PARP1 Signaling – Mol Neurobiol (2023)

  5. 🧫 N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson’s disease – Aging Cell (2024)

  6. 🦠 SARS-CoV-2: Underestimated damage to nervous system – Travel Med Infect Dis (2020)

  7. 💊 Potential therapeutic drugs for ischemic stroke based on bioinformatics analysis – Int J Neurosci (2019)

  8. 🧬 PTPN22 Gene Polymorphisms and Stroke Susceptibility – Dis Markers (2019)

  9. 🧪 IL-18 Gene Polymorphisms and Risk of Ischemic Stroke: A Meta-analysis – Neuroreport (2019)

  10. 🚬 Aromatic hydrocarbon receptor links smoking and rheumatoid arthritis – Clin Exp Rheumatol (2020)

🧾 Conclusion:

Dr. Lingyan Zhou demonstrates an exceptional trajectory for a young neuroscience researcher. Her deep and original contributions to unraveling molecular mechanisms in neurodegeneration, particularly Parkinson’s and Alzheimer’s disease, make her highly deserving of recognition. The breadth and quality of her publication record—combined with her translational outlook—signal a rising star in neurodegenerative disease research.